future of glp 1 drugs GLP-1 Drugs: Where We Are and Where We're Going — Summit Re GLP-1 Pipeline Update: February 2025

At hormonal levels, Copper Tripeptide-1 acts as a chemoattractant for fibroblasts (repairing cells) and activates a plethora of regenerative processes in the skin, such as angiogenesis, production of extracellular matrix components, including collagen, elastin, proteoglycans, glycosaminoglycans, etc, additionally activating metalloproteinases (MMPs) involved in tissue remodeling

For instance, compounds such as curcumin, resveratrol, and epigallocatechin gallate have been investigated in Phase I and Phase II studies for indications including cancer, metabolic disorders, and inflammatory diseases

BPC-157 Dosing Protocol & Schedule BPC-157 has been studied in two main research formats

Some research found that L-carnitine supplementation may help promote weight loss

A subsequent study involving 38 subjects over 16 weeks suggested that the peptide exhibited a positive research profile in these laboratory settings, with improvement reported across all subjects studied